Orion Oyj (ORINF) to Release Quarterly Earnings on Thursday

Orion Oyj (OTCMKTS:ORINF) is expected to announce its resultson Thursday, April 23rd. Analysts expect the company to announce earnings of $0.6760 per share and revenue of $415.1720 million for the quarter.

Orion Oyj Price Performance

OTCMKTS ORINF opened at $82.75 on Wednesday. The business has a 50 day simple moving average of $80.04 and a 200 day simple moving average of $80.80. Orion Oyj has a one year low of $78.95 and a one year high of $82.75.

About Orion Oyj

Orion Oyj is a Finland-based pharmaceutical and diagnostic products company that develops, manufactures and markets both human and veterinary medicines, diagnostic tests and active pharmaceutical ingredients. With a history dating back to its founding in 1917, the company has evolved into a diversified life science group, offering prescription and over-the-counter products for neurological, respiratory, cardiovascular and urological conditions, among others. Orion’s human pharmaceuticals portfolio includes well-known treatments for Parkinson’s disease, hormone therapy and erectile dysfunction, while its veterinary range addresses animal health needs such as pain management and dermatology.

In its Diagnostics segment, Orion produces laboratory tests and instruments for clinical chemistry and immunoassay applications, focusing on hormone and drug monitoring.